Authors
Rosie Wardle(FAIRR Initiative), Emma Rose (Alliance to SaveOur Antibiotics) & Abigail Herron (Aviva Investors)
This report provides a basic primer for investors on how to understand a company’s strategy to manage and mitigate antibiotic risk. Preserving the efficacy of our antibiotics for the future will require a fundamental shift away from routine reliance on antibiotics in farming, towards a health oriented system of rearing animals. The sheer scale of this change will require a system-wide approach to tackle antibiotic use; from livestock farmers, producers, food retailers, pharmaceutical companies and policymakers at local, regional, national and global levels. By investing in livestock systems and businesses which exhibit low risk, and by engaging with existing portfolio companies on responsible antibiotic use, investors can manage risk. Identifying and addressing the risks associated with the overuse of antibiotics in farming could present commercial opportunities, by improving company brand value and addressing consumer concern.